Seong-Jin Kim
Founder at MEDPACTO, INC.
Net worth: 24 M $ as of 2024-03-30
Profile
Seong-Jin Kim is the founder of MedPacto, Inc., Celloram, Inc. He is currently the Head of the Cancer Institute at CHA University.
Previously, he worked as an Independent Director and Head of Research & Development at THERAGEN ETEX Co., Ltd.
He holds a doctorate degree from the University of Tsukuba.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MEDPACTO, INC.
6.40% | 2023-12-21 | 2,149,334 ( 6.40% ) | 21 M $ | 2024-03-30 |
THERAGEN ETEX CO., LTD
3.26% | 2022-12-30 | 1,059,025 ( 3.26% ) | 3 M $ | 2024-03-30 |
Seong-Jin Kim active positions
| Companies | Position | Start |
|---|---|---|
| MEDPACTO, INC. | Founder | 2013-06-18 |
| CHA University | Corporate Officer/Principal | 2011-06-30 |
Celloram, Inc.
 Celloram, Inc. BiotechnologyHealth Technology Celloram, Inc. develops cellular immunotherapies to fight against cancer and metabolic disorders. The company is based in Cleveland, OH. The company was founded in 2018 by John Letterio, Seong-Jin Kim. The CEO is Tej Pareek. | Founder | - |
Former positions of Seong-Jin Kim
| Companies | Position | End |
|---|---|---|
| THERAGEN ETEX CO.,LTD. | Chief Tech/Sci/R&D Officer | - |
Training of Seong-Jin Kim
| University of Tsukuba | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| THERAGEN ETEX Co., Ltd. | |
| MedPacto, Inc. | |
Celloram, Inc.
Celloram, Inc. BiotechnologyHealth Technology Celloram, Inc. develops cellular immunotherapies to fight against cancer and metabolic disorders. The company is based in Cleveland, OH. The company was founded in 2018 by John Letterio, Seong-Jin Kim. The CEO is Tej Pareek. | Health Technology |
- Stock Market
- Insiders
- Seong-Jin Kim